CALL - SPRINTER OPEN END - MERCK & CO. Share Price

Certificat

DE000VM542J2

Delayed Deutsche Boerse AG 01:44:30 26/06/2024 pm IST
4.15 EUR -0.95% Intraday chart for CALL - SPRINTER OPEN END - MERCK & CO.
Current month+22.87%
1 month+9.40%
Date Price Change
26/24/26 4.15 -0.95%
25/24/25 4.19 +1.95%
24/24/24 4.11 +5.66%
21/24/21 3.89 +0.26%
20/24/20 3.88 +6.59%

Delayed Quote Deutsche Boerse AG

Last update June 26, 2024 at 01:44 pm IST

More quotes

Static data

Product typeKnock-Out ohne Stop Loss
Buy / SellCALL
Underlying MERCK & CO., INC.
IssuerLogo Issuer Vontobel Vontobel
WKN VM542J
ISINDE000VM542J2
Date issued 29/11/2023
Strike 88.7 $
Maturity Unlimited
Parity 10 : 1
Emission price 1.41
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 4.23
Lowest since issue 1.43
Spread 0.08
Spread %1.89%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
132.9 USD
Average target price
142.7 USD
Spread / Average Target
+7.34%
Consensus